Recent Technical Updates on HealthCare Stocks- Research on Edge Therapeutics, Castlight Health, Trevena and Omeros

NEW YORK, NY / ACCESSWIRE / November 03, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Edge Therapeutics, Inc (NASDAQ: EDGE), Castlight Health Inc (NYSE: CSLT), Trevena Inc (NASDAQ: TRVN) and Omeros Corp (NASDAQ: OMER). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.

To access our full PDF reports for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

EDGE Research Report: http://www.traders-choice.com/pdf?s=EDGE

CSLT Research Report: http://www.traders-choice.com/pdf?s=CSLT

TRVN Research Report: http://www.traders-choice.com/pdf?s=TRVN

OMER Research Report: http://www.traders-choice.com/pdf?s=OMER

============

Highlights from today's reports include:

On Monday, November 02, 2015, the NASDAQ Composite ended at 5,127.15, up 1.45%, the Dow Jones Industrial Average advanced 0.94%, to finish the day at 17,828.76, and the S&P 500 closed at 2,104.05, up 1.19%.

- Edge Therapeutics Inc's stock decreased 7.77% to close Monday's session at USD 16.49. The company's shares fluctuated in the range of USD 15.50 and USD 19.39. A total of 0.12 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.09 million shares and was below its 52-week average volume of 0.19 million shares. Over the last three days, Edge Therapeutics Inc's shares have declined by 21.02% and in the past one week it has moved down 18.73%. The stock has a market capitalization of USD 453.4 million and a price to book ratio of 9.4. The stock is trading 18.75% below its 20-day simple moving averages. Recently, on October 12, 2015, Edge Therapeutics, Inc. announced that the European Commission (EC) has granted orphan drug designation to its lead product candidate - EG-1962, which is in development for treating patients that have suffered an aneurysmal subarachnoid hemorrhage (aSAH), also known as a ruptured brain aneurysm.

- Castlight Health Inc's stock added 0.59% to close Monday's session at USD 5.09. The company's shares oscillated between USD 5.03 and USD 5.18. The stock recorded a trading volume of 0.39 million shares, which was below its 50-day daily average volume of 0.68 million shares and below its 52-week average volume of 0.71 million shares. Over the last five days, Castlight Health Inc's shares have advanced 11.14% and in the past one month, it has gained a momentum of 26.30%. However, over the last three months, the stock has lost 27.90% and year to date, the shares have shed 56.50%. The stock has a market capitalization of USD 480.1 million and it is trading at a price to book ratio of 3.3 and price to sales ratio of 7.8. The stock has 50-Day Moving Average and 200-Day Moving Average of USD 4.90 and USD 7.19, respectively. The stock is also trading 9.95% above its 20-day simple moving averages.

- Trevena Inc's stock advanced 3.22% to close Monday's session at USD 9.93. The share price vacillated between USD 9.58 and USD 10.17. The stock recorded a trading volume of 0.39 million shares, which was below its 50-day daily average volume of 1.95 million shares and below its 52-week average volume of 0.58 million shares. Over the last three days, Trevena Inc's shares have declined by 3.97% and in the past one week it has moved down 0.80%. However, in the last six months, the stock has gained 43.08% and year to date, the shares have picked up 66.05%. The stock has a market capitalization of USD 427.6 million and it is trading at a price to book ratio of 4.6 and price to sales ratio of 135.1. The stock has 50-Day Moving Average and 200-Day Moving Average of USD 10.16 and USD 7.32, respectively. The stock is also trading 1.40% below its 20-day simple moving averages.

- Omeros Corp's stock edged higher by 10.06% to close Monday's session at USD 13.79. The company's shares oscillated between USD 12.55 and USD 14.05. The stock recorded a trading volume of 0.41 million shares, which was below its 50-day daily average volume of 0.91 million shares and below its 52-week average volume of 0.72 million shares. Over the last three days, Omeros Corp's shares have advanced 7.07% and in the past one week it has moved up 7.57%. However, over the last three months, the stock has lost 13.38% and in the past six months, the shares have shed 34.52%. The stock has a market capitalization of USD 522.4 million and it is trading 10.41% above its 20-day simple moving averages. The stock is also trading price to book ratio of 6.9, price to sales ratio of 123.7 and has 50-Day Moving Average and 200-Day Moving Average of USD 12.92 and USD 18.75, respectively.

--

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.